REGN fund manager activity
Regeneron Pharmaceuticals, Inc · Nasdaq. Reported by 15 tracked fund managers in their 13F filings, Q2 2013 to Q2 2026.
Q2 2026
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|
| Dodge & Cox Funds | Added | 4,871,137 | $3,037,348,765 | 1.59% | Aug 13, 2026 |
| Ken Fisher - Fisher Asset Management | Sold out | — | — | 0.00% | Aug 4, 2026 |
| Jeremy Grantham - GMO | Added | 74,200 | $46,266,668 | 0.10% | Aug 13, 2026 |
| Joel Greenblatt - Gotham Asset Management | Added | 105,165 | $65,574,584 | 0.15% | Aug 14, 2026 |
| Harry Burn - Sound Shore | Trimmed | 126,994 | $79,185,839 | 2.44% | Aug 12, 2026 |
| Mason Hawkins - Southeastern Asset Management | Added | 152,322 | $94,978,860 | 4.95% | Aug 14, 2026 |
Q1 2026
| Manager | Activity | Shares | Value | % of portfolio | Filed |
|---|
| Dodge & Cox Funds | Trimmed | 4,458,238 | $3,444,613,008 | 1.89% | May 14, 2026 |
| Ken Fisher - Fisher Asset Management | Added | 5,059 | $3,909,303 | 0.00% | May 5, 2026 |
| Jeremy Grantham - GMO | Trimmed | 55,353 | $42,767,942 | 0.11% | May 14, 2026 |
| Joel Greenblatt - Gotham Asset Management | Added | 82,846 | $64,010,133 | 0.20% | May 15, 2026 |
| Harry Burn - Sound Shore | Trimmed | 150,960 | $116,637,734 | 3.91% | May 7, 2026 |
| Mason Hawkins - Southeastern Asset Management | Trimmed | 130,662 | $100,954,687 | 4.97% | May 15, 2026 |
Older quarters